Proteomics & Protein Research
News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
Quanterix Counting on Multi-Marker Approach as Differentiator in Crowded Alzheimer's Dx Field
Premium
The company expects its five-marker LucentAD Complete test to offer higher performance than single-marker assay and to secure higher reimbursement.
PrognomiQ Closes $34M Series D Round
The company said it will use the funding for development of its blood-based early detection test for lung cancer, which it plans to offer initially as an LDT and then as an IVD.
Standard BioTools Q3 2024 Revenues Fall 5 Percent
The company posted total revenues of $45.0 million, down from pro forma revenues of $47.4 million in Q3 2023 but beating the consensus Wall Street estimate of $41.0 million.
ARPA-H Awards $110M to Commercial, Academic Teams Tackling Women's Health
The awardees included several diagnostics firms, among them Aspira Women's Health, which received $10 million for development of its EndoMDx test.
Aspira Receives NY State Approval for OvaWatch Test
Aspira can now offer the test, intended for assessing ovarian cancer risk in women with an adnexal mass, to patients in New York state.